You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest
Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch
Settlement Date Short Interest Percent Change
Average Daily Share Volume Days to Cover
04/29/2022 82,394 (9.27) 22,137 3.72
04/14/2022 90,811 23.95 47,392 1.92
03/31/2022 73,266 (42.79) 65,105 1.13
03/15/2022 128,075 (14.39) 47,132 2.72
02/28/2022 149,597 (13.52) 21,166 7.07
02/15/2022 172,991 (28.49) 42,199 4.10
01/31/2022 241,922 (46.03) 165,710 1.46
01/14/2022 448,233 (25.38) 346,134 1.29
12/31/2021 600,696 (51.92) 628,412 1.00
12/15/2021 1,249,480 47717.83 7,280,845 1.00
11/30/2021 2,613 (34.49) 22,632,999 1.00
11/15/2021 3,989 (95.41) 102,287 1.00
10/29/2021 86,964 7.22 26,424 3.29
10/15/2021 81,107 (0.08) 29,832 2.72
09/30/2021 81,168 (24.11) 20,302 4.00
09/15/2021 106,956 21.94 26,331 4.06
08/31/2021 87,712 (2.23) 26,402 3.32
08/13/2021 89,714 4.18 20,032 4.48
07/30/2021 86,114 (3.20) 19,243 4.48
07/15/2021 88,957 (18.41) 31,149 2.86
06/30/2021 109,027 3.41 21,339 5.11
06/15/2021 105,427 2.04 37,914 2.78
05/28/2021 103,316 2.20 29,626 3.49
05/14/2021 101,096 0.78 27,897 3.62
04/30/2021 100,312 (6.00) 21,561 4.65
04/15/2021 106,716 5.36 30,033 3.55
03/31/2021 101,286 (4.91) 24,409 4.15
03/15/2021 106,515 3.11 56,041 1.90
02/26/2021 103,304 2.54 76,050 1.36
02/12/2021 100,744 2.07 75,289 1.34
Recent CPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:10:30 PM
- Cumberland Pharmaceuticals Reports Annual 2023 Financial Results • PR Newswire (US) • 03/05/2024 09:05:00 PM
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS • PR Newswire (US) • 02/27/2024 09:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 10:27:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:11:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:10:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:08:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/27/2023 05:15:30 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/15/2023 09:14:42 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/14/2023 10:09:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 10:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 10:04:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 10:03:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 10:02:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:21:37 PM
- Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/07/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:05:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:02:00 PM
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS • PR Newswire (US) • 10/31/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 09:04:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 01:11:16 PM
- NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE • PR Newswire (US) • 10/10/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 09:05:42 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM